Kazia Therapeutics

-$0.33 (-3.29%) As of 2:10 PM UTC today

Why Robinhood?

You can buy or sell KZIA and other stocks, options, and ETFs commission-free!

About KZIA

Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil.

CEO
James Garner
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1994

KZIA Key Statistics

Market Cap
126.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
85.71K
High Today
$9.90
Low Today
$9.40
Open Price
$9.89
Volume
27.02K
52 Week High
$15.85
52 Week Low
$3.12

KZIA Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Jul 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure